23andMe Phase 1 Trial is an Immunotherapy for treating advanced solid tumors
A new Phase 1 Immunotherapy trial using genetic sequencing to address patients with metastatic solid tumors.
Call Us: 301-352-3042
A new Phase 1 Immunotherapy trial using genetic sequencing to address patients with metastatic solid tumors.